TAMIKO GAY: Open Payments
NPI 1194459396 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,546 in 144 payments from 14 companies in 2025. Trend: 2023 $958 · 2024 $1,528 · 2025 $2,546
Food & beverage: $2,431Education: $116
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $392 |
| Alkermes, Inc. | 16 | $297 |
| Neurocrine BioSciences, Inc. | 17 | $294 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $283 |
| Lundbeck LLC | 16 | $259 |
| ABBVIE INC. | 14 | $212 |
| Vanda Pharmaceuticals Inc. | 17 | $203 |
| Otsuka America Pharmaceutical, Inc. | 11 | $177 |
| E.R. Squibb & Sons, L.L.C. | 12 | $165 |
| Janssen Pharmaceuticals, Inc | 10 | $149 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, CAPLYTA, VRAYLAR, FANAPT, COBENFY, ARISTADA.
Industry payments across LA — which companies pay providers there.
